RecruitingPhase 3NCT06719141
A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathies (DEE)
Studying KCNQ2-related developmental and epileptic encephalopathy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Longboard Pharmaceuticals
- Principal Investigator
- Email contact via H. Lundbeck A/S
- Intervention
- LP352(drug)
- Enrollment
- 320 enrolled
- Eligibility
- 2-65 years · All sexes
- Timeline
- 2024 – 2026
Study locations (20)
- Arkansas Children's Hospital - PIN, Little Rock, Arkansas, United States
- Children's Hospital Los Angeles - PIN, Los Angeles, California, United States
- David Geffen School of Medicine at UCLA, Los Angeles, California, United States
- The Stanford Division of Child Neurology, Palo Alto, California, United States
- UCSF Children's Hospital, San Francisco, California, United States
- Children's Hospital Colorado., Aurora, Colorado, United States
- Children's National Medical Center, Washington D.C., District of Columbia, United States
- NW FL Clinical Research Group, LLC, Gulf Breeze, Florida, United States
- University of Miami - 1120 NW 14th St, Miami, Florida, United States
- Nicklaus Children's Hospital - PIN, Miami, Florida, United States
- Research Institute of Orlando LLC, Orlando, Florida, United States
- University of South Florida - 2 Tampa General Circle, Tampa, Florida, United States
- Pediatric Epilepsy and Neurology Specialists, Tampa, Florida, United States
- Children's Healthcare of Atlanta - Center for Advanced Pediatrics - PIN, Atlanta, Georgia, United States
- Rare Disease Research, LLC - Atlanta - RDR - PIN, Atlanta, Georgia, United States
- +5 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06719141 on ClinicalTrials.govOther trials for KCNQ2-related developmental and epileptic encephalopathy
Additional recruiting or active studies for the same condition.
See all trials for KCNQ2-related developmental and epileptic encephalopathy →